Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

BIEL
BIOELECTRONICS CORP
stock OTC

EOD
Jul 31, 2026
0.000300USD0.000%(0.000000)5,857,400
Pre-market
0.00USD-100.000%(0.00)0
After-hours
0.00USD0.000%(0.00)0
OverviewHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 3, 2022
06:00AM EST  BioElectronics Corporation Announces Major Lenders Forgoing   GlobeNewswire Inc
Nov 16, 2021
07:00AM EST  BioElectronics Corporation Reports Q3 Earnings   GlobeNewswire Inc
Oct 7, 2021
07:00AM EDT  BioElectronics Corporation to Present at the NobleCon Online Pain   GlobeNewswire Inc
Aug 30, 2021
08:00AM EDT  BioElectronics Corporation Discusses Q2 Financials   GlobeNewswire Inc
Apr 19, 2021
07:00AM EDT  via NewMediaWire -- BioElectronics Corporation ( https://www.bielcorp.com/ OTC PINK: BIEL) is pleased to report Q1 2021 revenue figures, the progress on three different product launches into the OTC and medical markets, ongoing efforts to expand international distribution, and finally, new initiatives into strengthening R&D/manufacturing capabilities.   GlobeNewswire Inc
Jan 19, 2021
08:30AM EST  via NewMediaWire -- BioElectronics Corporation (OTC PINK:BIEL) is pleased to report that Q4 revenue for 2020 exceeded $519,000, representing an increase of 241% when compared to Q3 revenue in 2020 ($151,956). Correspondingly, Q4 2020 revenue represents an increase of 233% when compared to the cumulative revenue of Q1 and Q2 in 2020 ($155,818).   GlobeNewswire Inc
Dec 15, 2020
07:20AM EST  via NewMediaWire-- BioElectronics Corporation (OTC PINK: BIEL), (www.bielcorp.com) is pleased to announce that it has executed an OEM agreement with KT Health, LLC to bring its innovative pain management devices to encompass retail and e-commerce distribution throughout North America, as well as several additional key international markets.   GlobeNewswire Inc
Nov 12, 2020
07:00AM EST  BioElectronics Earns CE Mark for the ActiPatch and RecoveryRx --   GlobeNewswire Inc
Nov 6, 2020
08:05AM EST  BioElectronics' ActiPatch(r) Therapy To Be Marketed By DonJoy(r) Advantage   PR Newswire
Aug 10, 2020
07:42AM EDT  via NEWMEDIAWIRE BioElectronics Corporation (OTC: BIEL), (www.bielcorp.com) today released a Chairmans Letter to Shareholders written by Dr. Richard Staelin, the Companys Chairman of the Board.   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC